Please wait a minute...
文章检索
预防医学  2021, Vol. 33 Issue (3): 226-230    DOI: 10.19485/j.cnki.issn2096-5087.2021.03.003
  论著 本期目录 | 过刊浏览 | 高级检索 |
文山州HIV/AIDS抗病毒治疗病例艾滋病羞辱和歧视的影响因素分析
胡晓松1, 吕华坤1, 王慎玉1, 赵燕2, 黄玲玲3, 吴尊友2
1.浙江省疾病预防控制中心免疫规划所,浙江 杭州 310051;
2.中国疾病预防控制中心性病艾滋病预防控制中心;
3.文山市人民医院抗病毒治疗门诊
Associated factors for HIV stigma among the patients on antiretroviral therapy in Wenshan Prefecture
HU Xiaosong*, LÜ Huakun, WANG Shenyu, ZHAO Yan, HUANG Lingling, WU Zunyou
*Department of Immunization Planning, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang 310051, China
全文: PDF(868 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解云南省文山州抗病毒治疗门诊艾滋病病毒感染者和艾滋病患者(HIV/AIDS)艾滋病羞辱和歧视状况及影响因素,为消除艾滋病歧视提供参考。方法 于2017年10月—2018年1月,采用方便抽样方法选取文山州文山市和马关县3家艾滋病抗病毒治疗门诊治疗的HIV/AIDS病例进行问卷调查。采用李现红等编制的量表评估HIV/AIDS病例艾滋病羞辱和歧视状况。采用多重线性回归模型分析HIV/AIDS病例艾滋病羞辱和歧视的影响因素。结果 纳入HIV/AIDS病例419例,艾滋病羞辱和歧视总分中位数为68.00分,其中担心公开、内在羞辱、家庭歧视、公众歧视和医务人员歧视维度的得分中位数分别为24.00、20.00、10.00、6.00和2.00分。多重线性回归分析结果显示,女性(β'= 0.135)、发生机会性感染(β'= 0.120)、领取门诊激励礼物(β'= 0.124)的病例艾滋病羞辱和歧视评分较高;家人感染HIV(β'= -0.128)、获得家庭支持(β'= -0.175)、抗病毒治疗知识得分高(β'= -0.117)的病例艾滋病羞辱和歧视评分较低。结论 文山州艾滋病抗病毒治疗门诊HIV/AIDS病例担心公开和内在羞辱维度歧视情况较严重;性别、机会性感染、家人感染HIV、家庭支持、门诊激励礼物和抗病毒治疗认知是HIV/AIDS病例艾滋病羞辱和歧视的影响因素。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡晓松
吕华坤
王慎玉
赵燕
黄玲玲
吴尊友
关键词 艾滋病抗病毒治疗羞辱歧视    
AbstractObjective To learn HIV related stigma and its associated factors among the patients on antiretroviral therapy ( ART ) in Wenshan Prefecture, Yunnan Province, so as to provide evidence for eliminating HIV discrimination. Methods A total of 419 subjects were recruited by convenience sampling from three ART clinics in Wenshan City and Maguan County between October 2017 and January 2018. HIV/AIDS Related Stigma and Discrimination Scale developed by Li Xianhong et al was employed. The multivariate linear regression model were used to explore the influencing factors for HIV stigma. Results The median scores of disclosure concern, public rejection, family stigma, internalized stigma, health service providers' stigma were 24.00, 6.00, 10.00, 20.00, 2.00, respectively, and the overall was 68.00. The multivariate linear regression analysis showed that female patients ( standardized β=0.135 ) , patients with opportunistic infection ( standardized β=0.120 ), patients had no HIV infected family member ( standardized β=-0.128 ) , patients without family support ( standardized β=-0.175 ) , patients received gift from ART clinics ( standardized β=0.124 ) , patients scored lower in ART knowledge ( standardized β=-0.117 ) were likely to scored higher in HIV stigma. Conclusions The stigma on disclosure concern and internalized stigma dimensions are grievous among ART patients in Wenshan Prefecture. Gender, opportunistic infection, HIV infection in family, family support, receiving incentive gifts from clinics and awareness of ART are associated with HIV stigma.
Key wordsacquired immune deficiency syndrome    antiretroviral therapy    stigma    discrimination
收稿日期: 2020-10-26      修回日期: 2020-12-16      出版日期: 2021-03-10
中图分类号:  R512.91  
基金资助:艾滋病综合干预项目(XMSQ20171023_001)
作者简介: 胡晓松,硕士,医师,主要从事传染病防控与疫苗临床研究工作
通信作者: 吴尊友,E-mail:wuzy@263.net   
引用本文:   
胡晓松, 吕华坤, 王慎玉, 赵燕, 黄玲玲, 吴尊友. 文山州HIV/AIDS抗病毒治疗病例艾滋病羞辱和歧视的影响因素分析[J]. 预防医学, 2021, 33(3): 226-230.
HU Xiaosong, LÜ Huakun, WANG Shenyu, ZHAO Yan, HUANG Lingling, WU Zunyou. Associated factors for HIV stigma among the patients on antiretroviral therapy in Wenshan Prefecture. Preventive Medicine, 2021, 33(3): 226-230.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2021.03.003      或      https://www.zjyfyxzz.com/CN/Y2021/V33/I3/226
[1] 王科坤,杨银梅,姚星,等.武汉市HIV/AIDS病人感知歧视现状及相关因素分析[J] .中国艾滋病性病杂志,2018,24(7):667-670.
[2] KALICHMAN S,SHKEMBI B,HERNANDEZ D,et al.Income inequality,HIV stigma,and preventing HIV disease progression in rural communities[J] .Prev Sci,20(7):1066-1073.
[3] CORDEIRO DUTRA A F,CORDOVA W,AVANT F.Services,stigma,and discrimination:perceptions of African descendant men living with HIV/AIDS in Brazil and in the United States[J] .Soc Work Public Health,2018,33(4):226-236.
[4] 胡晓松,陈芳,丁凡,等.中国三城市HIV阳性男男性行为人群接受随访与抗病毒治疗服务状况及其影响因素分析[J] .中华预防医学杂志,2015,49(11):945-949.
[5] CHAMBERS L A,RUEDA S,BAKER D N,et al.Stigma,HIV and health:a qualitative synthesis[J] .BMC Public Health,2015,15:848.
[6] PANTELIC M,BOYES M,CLUVER L,et al.They say HIV is a punishment from god or from ancestors':cross-cultural adaptation and psychometric assessment of an HIV stigma scale for South African adolescents living with HIV(ALHIV-SS)[J] .Child Indic Res,2018,11(1):207-223.
[7] HUA J,EMRICK C B,GOLIN C E,et al.HIV and Stigma in Liuzhou,China[J] .AIDS Behav,2014,18(Suppl. 2):S203-S211.
[8] 李现红,何国平,王红红,等.HIV/AIDS相关羞辱和歧视量表的编制及评价[J] .中国护理杂志,2010,45(6):496-499.
[9] 陈然,王瑜,余建英,等.PHQ-9在综合医院住院患者中信效度研究[J] .四川精神卫生杂志,2017,30(2):149-153.
[10] 孙振晓,孙宇新,于相芬,等.广泛性焦虑量表在颈椎病患者焦虑情绪评估的信度和效度研究[J] .临床精神医学杂志,2017,27(4):250-252.
[11] 何筱衍,李春波,钱洁,等.广泛性焦虑量表在综合性医院的信度和效度研究[J] .上海精神医学杂志,2010,22(4):200-203.
[12] 胡晓松,赵燕,吴尊友.云南省文山州HIV感染者抗病毒治疗脱失影响因素的定性研究[J] .中华疾病控制杂志,2018,22(8):822-825.
[13] SIRIL H N,KAAYA S F,SMITH FAWZI M K,et al.Clinical outcomes and loss to follow-up among people living with HIV participating in the NAMWEZA intervention in Dar es Salaam,Tanzania:a prospective cohort study[J] .AIDS Res Ther,2017,14(1):18.
[14] 罗珊霞,杨冬菊,黄霞,等.HIV感染者与AIDS患者感知歧视影响因素的横断面调查[J] .中国循证医学杂志,2018,18(6):560-564.
[15] LETSHWENYO-MARUATONA S B,MADISA M,BOITSHWARELO T,et al.Association between HIV/AIDS knowledge and stigma towards people living with HIV/AIDS in Botswana[J] .AJAR,2019,18(1):58-64.
[16] MANCINELLI S,NIELSEN-SAINES K,GERMANO P,et al.Who will be lost? Identifying patients at risk of loss to follow-up in Malawi.The DREAM Program Experience[J] .HIV Med,2017,18(8):573-579.
[17] NYBLADE L,STOCKTON M A,GIGER K,et al.Stigma in health facilities:why it matters and how we can change it[J] .BMC Med,2019,17(1):25.
[18] LEE H J,KIM D H,NA Y J,et al.Factors associated with HIV/AIDS-related stigma and discrimination by medical professionals in Korea:a survey of infectious disease specialists in Korea[J] .Niger J Clin Pract,2019,22(5):675-681.
[19] AKILIMALI P Z,MUSUMARI P M,KASHALA-ABOTNES E,et al.Disclosure of HIV status and its impact on the loss in the follow-up of HIV-infected patients on potent anti-retroviral therapy programs in a(post-)conflict setting:a retrospective cohort study from Goma,Democratic Republic of Congo[J] .PLoS One,2017,12(2):e0171407.
[20] OJWANG'V O,PENNER J,BLAT C,et al.Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu,Kenya[J] .AIDS Care,2016,28(4):500-507.
[21] MBERI M N,KUONZA L R,DUBE N M,et al.Determinants of loss to follow-up in patients on antiretroviral treatment,South Africa,2004-2012:a cohort study[J] .BMC Health Serv Res,2015,15:259.
[22] 樊鹏飞,杨晴,毛宇嵘,等.江西省农村地区HIV感染者接受基层医疗卫生机构随访管理现状及相关因素分析[J] .中华流行病学杂志,2019,40(3):346-349.
[1] 徐光明, 张震, 叶小红. 2015—2024年临海市新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2026, 38(1): 71-74.
[2] 苏德华, 陈向阳, 李君, 赵丽娜, 张鹤美, 朱婷婷, 胡文雪, 赖江宜. 温州市新报告HIV/AIDS病例抗病毒治疗及时性分析[J]. 预防医学, 2025, 37(8): 804-808.
[3] 徐莉, 刘萍, 卞宇旬, 陈圆媛, 李鑫娜, 周乐. 扬州市新报告50岁及以上HIV/AIDS病例抗病毒治疗前耐药分析[J]. 预防医学, 2025, 37(8): 779-782,788.
[4] 李瑶, 杨景元, 杨虹, 李向春, 孔瑞琴, 刘静, 白宝宝, 张艳萍, 李慧. 内蒙古自治区艾滋病自愿咨询检测门诊求询者特征分析[J]. 预防医学, 2025, 37(4): 356-360.
[5] 李倩, 杨柏林, 陈积标, 尹寒露, 许祝平, 孟晓军. 无锡市50岁及以上HIV/AIDS抗病毒治疗病例自报慢性病资料分析[J]. 预防医学, 2025, 37(4): 390-394.
[6] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[7] 王苓, 许珂, 张兴亮, 黄思超, 李西婷, 陈珺芳. 2022年杭州市新报告HIV/AIDS病例感染特征分析[J]. 预防医学, 2025, 37(2): 123-129.
[8] 钟郁媛, 许鑫慧, 王嘉川, 门娅玲, 李羽恒, 顾仁君, 王红妹. 老年HIV/AIDS病例心理弹性在艾滋病相关压力与患者报告结局间的中介效应分析[J]. 预防医学, 2025, 37(12): 1189-1194.
[9] 杨文涛, 张宏, 朱士玉, 徐娜, 杨志远, 朱建明, 宋灿磊. HIV/AIDS病例生存质量的影响因素研究[J]. 预防医学, 2025, 37(12): 1195-1200.
[10] 丁晨, 刘家虹, 吴争, 熊长辉. 江西省部分地区HIV/AIDS病例HIV-1分子传播网络分析[J]. 预防医学, 2024, 36(9): 764-767.
[11] 戴色莺, 沈月兰, 刘爱文, 张进, 吴家兵. 安徽省男性流动人口艾滋病相关知识和HIV感染情况调查[J]. 预防医学, 2024, 36(8): 674-678,682.
[12] 王慧, 李锦成, 陆兴, 王金富, 竺丽梅, 刘巧. 重组结核杆菌融合蛋白皮肤试验筛查HIV/AIDS病例结核分枝杆菌潜伏感染的效果分析[J]. 预防医学, 2024, 36(7): 639-643.
[13] 何婷婷, 曹栋卿, 林家锋, 蒋卓婧, 张佳峰, 范钦. 绍兴市MSM人群HIV-1分子传播网络特征分析[J]. 预防医学, 2024, 36(7): 571-575,579.
[14] 贾晓锋, 王慧群, 石敏, 汤婕, 任静霞. HIV/AIDS病例HIV相关神经认知障碍的影响因素分析[J]. 预防医学, 2024, 36(6): 461-464.
[15] 夏永玲, 张海芳, 陶桃, 蓝黄琛, 陈晓蕾, 吴振宇. 丽水市MSM人群HIV定期检测及暴露后预防调查[J]. 预防医学, 2024, 36(6): 465-469.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed